![Robert R. Redfield](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert R. Redfield
Direttore/Membro del Consiglio presso Viriom, Inc.
Profilo
Robert R.
Redfield founded Profectus BioSciences, Inc. in 2003.
Dr. Redfield also currently works at Viriom, Inc., as Director.
Posizioni attive di Robert R. Redfield
Società | Posizione | Inizio |
---|---|---|
Viriom, Inc.
![]() Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Robert R. Redfield
Società | Posizione | Fine |
---|---|---|
Profectus BioSciences, Inc.
![]() Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Profectus BioSciences, Inc.
![]() Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Viriom, Inc.
![]() Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Commercial Services |
- Borsa valori
- Insiders
- Robert R. Redfield